Exciting insights from our #AACR24 presentation! Our latest studies confirm that our Decoy technology activates not just the innate but also the adaptive immune system. Plus, promising synergies with IL-2 could enhance combination therapies. Dive into the full discussion!
$INDP…

RMC-5127, a First-in-Class, Orally Bioavailable RAS(ON) G12V-Selective Tri-Complex Inhibitor,
is CNS-Penetrant and Drives Regressions in Intracranially Implanted #KRAS G12V Xenograft Tumors
#AACR24 🎯

Are cancer vaccines ready for prime time? Highlights from our Johns Hopkins Kimmel Cancer Center study of an off-the-shelf mutant KRAS vaccine in individuals at high risk of developing pancreatic cancer are featured here #AACR24
cancertodaymag.org/cancer-talk/va…

#AACR24 was a whirlwind of exciting breakthroughs like activating the immune system to fight cancer through #Immunotherapy

Advancements like these play a crucial role in offering patients a fighting chance. Explore our approach in #oncology : curadev.in/immune-oncology

After two years of participating in the AACR Scientist Survivor program this year I got to mentor a group along side the amazing scientific mentor Jerry SH Lee - Allison Rosen, MS
Bayer Oncology Medical

#AACR24 #Cancer #Cancer Research #OncoDaily #Oncology #Mentorship

oncodaily.com/54779.html

Missed this year’s #AACR24 meeting? Visit the #Arvinas #Medical congress site to learn more about preclinical data from our #PROTAC BCL6 degrader for #non -Hodgkin #lymphoma

Click here to learn more: bit.ly/3t3wQaq

Throwback to earlier this month: Simon Gregory presenting our work on the Akoya Biosciences platform, studying the spatial biology of #gliomas at #AACR24 ! 🧠💻🧬

#CancerResearchSavesLives #spatialbiology

Incredibly grateful to AACR for the support! Enjoyed connecting with other awardees and colleagues at the AACR Grants Award Reception at #AACR24 . #MECCC

Last month at #AACR24 , President and CEO of Lankenau Institute for Medical Research, George Prendergast, Ph.D., spoke with VJ Oncology about preclinical modeling of the #SYNCT combination multi-target immunotherapy. View the video interviews here: bit.ly/44lt2QB

In this interview from #AACR24 , Shawn Levy from Element Biosciences talks about #AVITI24 , their new multiomics platform that can provide deeper insights into cancer biology.
biotechniques.com/molecular-biol…

Read a recap of 'AI at the Interface' at AACR 2024 plenary session in AACR Annual Meeting News - Vivek Subbiah, MD
Sarah Cannon Docs Anant Madabhushi Thomas Clozel Mia Levy, MD, PhD

#AACR24 #Cancer #Cancer Research #ClinicalTrial #OncoDaily #Oncology

oncodaily.com/54750.html

Mural Oncology’s Joshua Heiber & Mark Whitmore presented at the AACR Annual Meeting this month. Read their takeaways & learn more about the pre-clinical data from our interleukin-18 (IL-18) and IL-12 programs that were shared for the first time: bit.ly/4daBbLF

#AACR24

Join us in celebrating #NationalCancerResearchMonth this May! 🔬

RutgersCancerInstNJ with RWJBarnabas is dedicated to advancing #cancerresearch and providing state-of-the-art care for patients.

cinj.org/research/natio…

#AACR24 #cancercare Robert Wood Johnson University Hospital AACR

Congratulations to Dr. Lindsay LaFave on receiving the AACR Career Development Award in Lung Cancer Research! 🎊 This award will support research efforts to identify new therapeutic rationales in #LungCancer . Albert Einstein College of Medicine - Official #MECCC #MonteProud #AACR24

And a part of that #AACR24 fun is that I got a chance to present a collaborative study on mutational landscapes in the lung in a minisymposium. Many thanks to our collaborators at CU Anschutz Medical Campus and in the UK
The Mark Foundation for Cancer Research Lung Cancer Research Foundation CRUK Lung Centre Rosetrees Trust Ruth Strauss Foundation

Chances to see $MDNAF $MDNA.to at #ASCO24 are not high since the #AACR24 was few weeks ago & they presented new updated data.

Today at 10am ET ASCO will release all the abstracts & I would be very excited if $MDNAF got a poster too!

Post from CRG about strict ASCO & AACR

Unlock the potential of #ExtracellularVesicles (EVs) #Proteomics for non-invasive cancer monitoring! Delve into our #AACR24 collaboration with Nexosome Oncology, where our #TrueDiscovery ® services revealed cancer-specific biomarkers in EVs.
More: ow.ly/23mf50RsknU

At #AACR24 , collaborators presented positive preclinical data from studies of lead product candidate, Reqorsa® Therapy, as well as NPRL2 #genetherapy , which both utilize our Oncoprex® Delivery System for the treatment of lung cancer. Details: ow.ly/mmzG50RtHrA

AACR $GNPX

Cheered on 2 of my mentees who won travel awards, University of Iowa grad student Sarina Murray (Minority in Cancer Research Award Winner) and NCI CPFP Shariar Zamani (Scholar in Training Award Winner). I was beaming with pride for the both of them. #aacr24 #mentorship

Biomarker data from adjuvant ipi/nivo vs placebo study in renal cancer shows circulating Kidney injury marker-1(KIM-1), which is over expressed & prognostic in RCC #AACR24 , maybe important (along with PD-L1) in response to ipi/nivo. Patient selection for adjuvant IO is important